By Sam Boughedda A Morgan Stanley analyst upgraded shares of Regeneron (NASDAQ:REGN) to Overweight from Equal-Weight, raising the firm's price target on the stock to $851 from $625 in a note...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Friday, September 9th. Please refresh for updates. DocuSign (NASDAQ:DOCU) stock rose 16.9% after the software company...
By Yasin Ebrahim Investing.com -- The Dow closed higher Thursday after struggling for direction as Federal Reserve officials including chairman Jerome Powell vowed to continue the fight...
By Yasin Ebrahim Investing.com -- The S&P 500 climbed Thursday, in choppy trade as investors weighed up weakness in big tech and strength in banking stocks amid rising Treasury yields after...
By Sam Boughedda Regeneron (NASDAQ:REGN) shares jumped over 20% after the company said on Thursday that its anti-blindness treatment Eylea, jointly developed with Bayer (OTC:BAYRY), has met...
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (NASDAQ: SNY) presented detailed results from the second of two Phase 3 trials (PRIME) evaluating Dupixent (dupilumab) in adults...
These are the stocks posting the largest moves in midday trading.
Regeneron Pharmaceuticals Inc's (NASDAQ: REGN) two pivotal trials evaluating aflibercept 8 mg with 12- and 16-week dosing regimens met the primary endpoints in diabetic macular edema (DME)...
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Sanofi SA (NASDAQ: SNY) announced results from a Phase 3 open-label extension trial of Dupixent (dupilumab) as maintenance therapy in asthma...
Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) announced results from a Phase 2 study of cemdisiran for immunoglobulin A nephropathy (IgAN). Cemdisiran is an investigational RNAi therapeutic...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Wednesday, August 3rd. Please refresh for updates. CVS Health (NYSE:CVS) stock rose 4% after the pharmacy company...
By Peter Nurse Investing.com -- U.S. stocks are seen opening higher Wednesday, rebounding after the previous session’s losses, ahead of the release of key services activity data as...
Regeneron (NASDAQ:REGN) reported Q2 EPS of $9.77, $1.17 better than the analyst estimate of $8.60. Revenue for the quarter came in at $2.86 billion versus the consensus estimate of $2.79...
Investing.com - Regeneron Pharma (NASDAQ:REGN) reported on Wednesday second quarter {{erl-32391||earnings that beat analysts' forecasts and revenue that topped expectations. Regeneron...
By Oliver Gray Investing.com - U.S. stock futures traded higher during Tuesday’s evening deals, after major benchmark averages declined for a second consecutive day amid growing...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Technology, Basic Materials and Consumer Services sectors propelled shares higher. At the close in NYSE,...
Regeneron (NASDAQ:REGN) reported Q1 EPS of $11.49, $1.45 better than the analyst estimate of $10.04. Revenue for the quarter came in at $2.97 billion versus the consensus estimate of $2.73...
Investing.com - Regeneron Pharma (NASDAQ:REGN) reported on Wednesday first quarter {{erl-32391||earnings that beat analysts' forecasts and revenue that topped expectations. Regeneron...
By Sam Boughedda Investing.com -- Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced Tuesday that it will acquire Checkmate Pharmaceuticals (NASDAQ:CMPI) for $10.50 per share. The deal,...
By Sam Boughedda Investing.com -- U.S. stocks are trading higher Tuesday, with the Nasdaq the biggest gainer at +1.88%. Here are the midday movers on Tuesday, April 19th. Checkmate...
Pre-Open Stock Movers:Checkmate Pharmaceuticals, Inc. (CMPI) 332% HIGHER; Regeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (REGN) agreed to acquire the company for $10.50 per share in...
By Peter Nurse Investing.com -- Stocks in focus in premarket trade on Friday, February 4th. Please refresh for updates. Amazon (NASDAQ:AMZN) stock rose 12% after the online retail colossus...
By Peter Nurse Investing.com - U.S. stocks are seen opening in mixed fashion Friday, with the technology-dominated Nasdaq index outpeforming after strong earnings from Amazon...
Investing.com - Regeneron Pharma (NASDAQ:REGN) reported on Friday fourth quarter {{erl-32391||earnings that beat analysts' forecasts and revenue that topped expectations. Regeneron Pharma...
By Yasin Ebrahim Investing.com – The S&P 500 slumped Tuesday, after Federal Reserve Chairman Jerome Powell signaled a more aggressive approach to scale-back bond purchases at a time when...
By Sam Boughedda Stocks tumbled on Tuesday after Federal Reserve Chair Jerome Powell said the risk of inflation has increased and the central bank could speed up the timeline for cutting...
By Geoffrey Smith Investing.com -- U.S. stock markets opened lower on Tuesday but were well off the lows seen by futures in the overnight session as uncertainty continued to swirl around...
By Peter Nurse Investing.com -- Oil prices slumped Tuesday amid worries about the efficacy of the current vaccines to cope with the new Covid variant, raising fears of prolonged travel...
By Geoffrey Smith Investing.com -- Global markets fall back into risk-off mode as Moderna (NASDAQ:MRNA) CEO Stephane Bancel warns about the efficacy of his vaccine against the new...
By Sam Boughedda Investing.com — Adagio Therapeutics Inc (NASDAQ:ADGI) stock jumped 58% after {0|Morgan Stanley upgraded it to overweight from equal weight following the emergence of...
By Dhirendra Tripathi Investing.com – Merck stock (NYSE:MRK) traded 3.5% lower in Friday’s premarket while the company awaits details of FDA’s review of the Covid-19 pill it has jointly...
By Geoffrey Smith Investing.com -- Another winter, another Covid surge in Europe – and another lockdown and economic slowdown? The sense of déjà vu is powerful, but...
By Dhirendra Tripathi Investing.com – Pfizer stock (NYSE:PFE) rose 0.4% Thursday as the company said the U.S. government has placed a $5.29 billion order to buy 10 million treatment...
By Sam Boughedda Investing.com — At the end of the day on Friday, biotech firm Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced a share repurchase program of up to $3 billion. The...
By Geoffrey Smith Investing.com -- Bitcoin surges to a record high, a day after the Federal Reserve grumbles after the financial stability risks of crypto. Lael Brainard has been...
By Dhirendra Tripathi Investing.com – Regeneron Pharmaceuticals stock (NASDAQ:REGN) rose 1% on Monday after the company said a single dose of its antibody cocktail significantly reduces the...
Investing.com - Regeneron Pharma (NASDAQ:REGN) reported on Thursday third quarter {{erl-32391||earnings that beat analysts' forecasts and revenue that topped expectations. Regeneron Pharma...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
